C WorldWide Group’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | – | Sell |
-100,000
| Closed | -$977K | – | 100 |
|
|
2026
Q2 | $977K | Hold |
100,000
| – | – | 0.02% | 85 |
|
|
2026
Q1 | $557K | Hold |
100,000
| – | – | 0.01% | 92 |
|
|
2025
Q4 | $736K | Hold |
100,000
| – | – | 0.01% | 93 |
|
|
2025
Q3 | $654K | Hold |
100,000
| – | – | 0.01% | 92 |
|
|
2025
Q2 | $431K | Hold |
100,000
| – | – | 0.01% | 93 |
|
|
2025
Q1 | $374K | Hold |
100,000
| – | – | ﹤0.01% | 92 |
|
|
2024
Q4 | $1.01M | Hold |
100,000
| – | – | 0.01% | 84 |
|
|
2024
Q3 | $1.24M | Hold |
100,000
| – | – | 0.01% | 83 |
|
|
2024
Q2 | $1.3M | Hold |
100,000
| – | – | 0.01% | 84 |
|
|
2024
Q1 | $2.26M | Hold |
100,000
| – | – | 0.03% | 71 |
|
|
2023
Q4 | $1.3M | Hold |
100,000
| – | – | 0.02% | 80 |
|
|
2023
Q3 | $2.01M | Hold |
100,000
| – | – | 0.03% | 74 |
|
|
2023
Q2 | $2.68M | Hold |
100,000
| – | – | 0.03% | 71 |
|
|
2023
Q1 | $5.84M | Hold |
100,000
| – | – | 0.08% | 66 |
|
|
2022
Q4 | $5.1M | Hold |
100,000
| – | – | 0.07% | 57 |
|
|
2022
Q3 | $8.19M | Hold |
100,000
| – | – | 0.11% | 48 |
|
|
2022
Q2 | $6.76M | Hold |
100,000
| – | – | 0.08% | 52 |
|
|
2022
Q1 | $11.1M | Hold |
100,000
| – | – | 0.12% | 45 |
|
|
2021
Q4 | $9.6M | Buy |
100,000
+20,000
| +25% | +$1.99M | 0.09% | 49 |
|
|
2021
Q3 | $6.98M | Hold |
80,000
| – | – | 0.07% | 57 |
|
|
2021
Q2 | $12.4M | Hold |
80,000
| – | – | 0.13% | 46 |
|
|
2021
Q1 | $12.6M | Buy |
80,000
+40,000
| +100% | +$8.43M | 0.12% | 51 |
|
|
2020
Q4 | $9.29M | Buy |
+40,000
| New | +$9.27M | 0.09% | 56 |
|
|
2018
Q4 | – | Sell |
-1,217
| Closed | -$311K | – | 128 |
|
|
2018
Q3 | $311K | Buy |
1,217
+176
| +17% | +$48.7K | ﹤0.01% | 121 |
|
|
2018
Q2 | $265K | Hold |
1,041
| – | – | ﹤0.01% | 119 |
|
|
2018
Q1 | $210K | Sell |
1,041
-29
| -3% | -$5.78K | ﹤0.01% | 118 |
|
|
2017
Q4 | $154K | Sell |
1,070
-164
| -13% | -$26.3K | ﹤0.01% | 120 |
|
|
2017
Q3 | $203K | Buy |
1,234
+189
| +18% | +$27.1K | ﹤0.01% | 122 |
|
|
2017
Q2 | $142K | Sell |
1,045
-84
| -7% | -$12.4K | ﹤0.01% | 126 |
|
|
2017
Q1 | $217K | Buy |
1,129
+262
| +30% | +$42.1K | ﹤0.01% | 119 |
|
|
2016
Q4 | $122K | Buy |
+867
| New | +$117K | ﹤0.01% | 123 |
|
Other funds holding KPTI
C WorldWide Group's KPTI Position: Q3 2026 in Review
C WorldWide Group sold out of Karyopharm Therapeutics (KPTI) in Q3 2026, closing a stake of 100,000 shares — an estimated $977K sold.
C WorldWide Group first reported a position in KPTI in Q4 2016 and held it in 31 quarters. The position peaked at $12.6M in Q1 2021. 47 funds tracked by Wall St. Rank hold KPTI as of Q3 2026.
- C WorldWide Group reported no remaining Karyopharm Therapeutics position as of Q3 2026 after selling out during the quarter.
- C WorldWide Group sold 100,000 Karyopharm Therapeutics shares in Q3 2026, an estimated $977K.
- C WorldWide Group first reported a position in Karyopharm Therapeutics in Q4 2016 and held it in 31 quarters.
- C WorldWide Group's Karyopharm Therapeutics position peaked at $12.6M in Q1 2021.
- 47 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2026.
Based on C WorldWide Group's 13F filing for Q3 2026, filed 4 Nov 2026.